Herpesvirus evasion of T-Cell immunity

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 1117-1136

  Gewurz, Benjamin E ^a   Vyas, Jatin M ^a   Ploegh, Hidde L ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929291868     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.063     Document Type: Chapter

References (158)

1. Abendroth, A. and Arvin, A. M. (2001). Immune evasion as a pathogenic mechanism of varicella zoster virus. Semin. Immunol., 13(1), 27-39.
2. Abendroth, A., Lin, I., Slobedman, B. et al. (2001a). Varicella-zoster virus retains major histocompatibility complex class II pro-teins in the Golgi compartment of infected cells. J. Virol., 75(10), 4878-4888.
3. Abendroth, A., Morrow, G., Cunningham, A. L. et al. (2001b). Varicella-zoster virus infection of human dendritic cells and transmission to T cells: Implications for virus dissemination in the host. J. Virol., 75(13), 6183-6192.
4. Abenes, G., Lee, M., Haghjoo, E. et al. (2001). Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice. J. Virol., 75(4), 1697-1707.
5. Ahn, K., Gruhler, A., Galocha, B. et al. (1997). The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity, 6(5), 613-621.
6. Aisenbrey, C., Sizun, C., Koch, J. et al.(2006). Structure and dynam-ics of membrane-associated ICP47, a viral inhibitor of the MHC I antigen processing machinery. J. Biol. Chem. Epub.
7. Andrews, D. M., Andoniou, C. E., Granucci, F. et al. (2001). Infection of dendritic cells by murine cytomegalovirus induces func-tional paralysis. Nat. Immunol., 2(11), 1077-1084.
8. Arase, H., Mocarski, E. S., Campbell, A. E. et al. (2002). Direct recog-nition of cytomegalovirus by activating and inhibitory NK cell receptors. Science, 296(5571), 1323-1326.
9. Arrode, G., Boccaccio, C., Abasrado, J. P. et al. (2002). Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells. J. Virol., 76(1), 142-150.
10. Barcy, S. and Corey, L. (2001). Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4+ T cells. J. Immunol., 166(10), 6242-6249.
11. Barel, M. T., Ressing, M., Pizzato, N. et al. (2003). Human cytomegalovirus-encoded US2 differentially affects surface expression of class II MHC locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J. Immunol., 171(12), 6757-6765.
12. Bartee, E., Mansouri, M., Hovey Nerenburg, B. T. et al. (2004). Downregulation of major histocompatibility complex class II by human ubiquitin ligases related to viral immune evasion proteins. J. Virol., 78(3), 1109-1120.
13. Beck, S. and Barrell, B. (1991). An HCMV reading frame which has similarity with both the V and C regions of the TCR gamma chain. DNA Seq, 2(1), 33-38.
14. Bennett, E. M., Bennink, J. R., Yewdell, J. W. et al. (1999). Cutting edge: Adenovirus E19 has two mechanisms for affecting class II MHC expression. J. Immunol., 162(9), 5049-5052.
15. Berger, C., Xuereb, S., Johnson, D. C. et al. (2000). Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cyto-toxic T lymphocytes. J. Virol., 74(10), 4465-4473.
16. Biron, C. A., Byron, K. S., and Sullivan, J. L. (1989). Severe her-pesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med., 320(26), 1731-1735.
17. Bjorkman, P. J., Saper, M. A., Samraoni, B. et al. (1987). Struc-ture of the human class II histocompatibility antigen, HLA-A2. Nature, 329(6139), 506-512.
18. Blake, N., Lee, S., Redchenko, I. et al. (1997). Human CD8+ T cell responses to EBV EBNA1: HLA class II presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity, 7(6), 791-802.
19. Blom, D., Hirsch, C., Stern, P. et al. (2004). A glycosylated type I mem-brane protein becomes cytosolic when peptide: N-glycanase is compromised. EMBO. J., 23(3), 650-658.
20. Borriello, F., Sethna, M. P., Boyd, S. D. et al. (1997). B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity, 6(3), 303-313.
21. Boss, J. M. (1997). Regulation of transcription of class II MHC genes. Curr. Opin. Immunol., 9(1), 107-113.
22. Britt, W. J. and Mach, M. (1996). Human cytomegalovirus glycopro-teins. Intervirology, 39(5-6), 401-412.
23. Brown, M. G., Driscoll, J., and Monaco, J. J. (1991). Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature, 353(6342), 355-357.
24. Bubic, I., Wagner, M., Krmpotic, A. et al. (2004). Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol., 78(14), 7536-7544.
25. Cadwell, K. and Coscoy, L. (2005). Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309(5731), 127-130.
26. Cebulla, C. M., Miller, D. M., Zhang, Y. et al. (2002). Human cytomegalovirus disrupts constitutive class II MHC expres-sion. J. Immunol., 169(1), 167-176.
27. Chevalier, M. S. and Johnson, D. C. (2003). Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class II and II protein degradation proper-ties. J. Virol., 77(8), 4731-4738.
28. Cho, N. H., Feng, P., Lee, S. H. et al. (2004a). Inhibition of T cell recep-tor signal transduction by tyrosine kinase-interacting protein of Herpesvirus saimiri. J. Exp. Med., 200(5), 681-687.
29. Cho, N. H., Wingston, D., Chang, N. et al. (2004b). Association of herpesvirus Saimiri Tip is essential for downregulation of T-cell receptor and CD4 coreceptor. J. Urol., 80(1), 108-118.
30. Coscoy, L. and Ganem, D. (2003). PHD domains and E3 ubiquitin ligases: Viruses make the connection. Trends Cell Biol., 13(1), 7-12.
31. Coscoy, L., Sanchez, D. J., and Ganem, D. (2001). A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recog-nition. J. Cell. Biol., 155(7), 1265-1273.
32. Cresswell, P. (2000). Intracellular surveillance: Controlling the assembly of MHC class I-peptide complexes. Traffic, 1(4), 301-305.
33. Crew, M. D. and Phanavanh, B. (2003). Exploiting virus stealth technology for xenotransplantation: Reduced human T cell responses to porcine cells expressing herpes simplex virus ICP47. Xenotransplantation, 10(1), 50-59.
34. Dantuma, N. P., Sharipo, A., and Masucci, M.G. (2002). Avoiding proteasomal processing: The case of EBNA1. Curr. Top. Micro-biol. Immunol., 269, 23-36.
35. de Campos-Lima, P. O., Gavioli, R., Zhang, Q. J. et al. (1993). HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science, 260(5104), 98-100.
36. Denzin, L. K. and Cresswell, P. (1995). HLA-DM induces CLIP dis-sociation from class II MHC alpha beta dimers and facilitates peptide loading. Cell, 82(1), 155-165.
37. Dodd, R. B., Allen, M. D., Brown, S. E. et al. (2004). Solution structure of the kaposi's sarcoma-associated herpesvirus K3 N-terminal domain reveals a novel E2-binding C4HC3-type RING domain. J. Biol. Chem.
38. Fiebiger, E., Story, C., Ploegh, H. L. et al. (2002). Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein. EMBO. J., 21(5), 1041-1053.
39. Flierman, D., Ye, Y., Dai, M. et al. (2003). Polyubiquitin serves as a recognition signal, rather than a ratcheting molecule, during retrotranslocation of proteins across the endoplasmic reticu-lum membrane. J. Biol. Chem., 278(37), 34774-34782.
40. Flierman, D., Coleman, C. S., Pickart, C. M. et al.(2006). E2-25K mediates US11-triggered retro-translocation of class II MHC heavy chains in a permeabilized cell system. Proc Natl Acad Sci 103(31), 11589-11594.
41. Freemont, P. S. (2000). RING for destruction? Curr. Biol., 10(2), R84-R87.
42. Fruh, K., Bartee, E., Gouveia, K. et al. (2002). Immune evasion by a novel family of viral PHD/LAP-Finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res., 88(1-2), 55-69.
43. Furman, M. H., Ploegh, H. L., and Schust, D. J. (2000). Can viruses help us to understand and classify the class II MHC molecules at the maternal-fetal interface? Hum. Immunol., 61(11), 1169-1176.
44. Furman, M. H., Ploegh, H. L., and Tortorella, D. (2002). Membrane-specific, host-derived factors are required for US2-and US11-mediated degradation of major histocompatibility complex class II molecules. J. Biol. Chem., 277(5), 3258-3267.
45. Furman, M. H., Loureiro, J., Ploegh, H. L. et al. (2003). Ubiquitiny-lation of the cytosolic domain of a type I membrane protein is not required to initiate its dislocation from the endoplasmic reticulum. J. Biol. Chem., 278(37), 34804-34811.
46. Galocha, B., Hill, A., Barnett, B.C. et al. (1997). The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. J. Exp. Med., 185(9), 1565-1572.
47. Gewurz, B. E., Gaudet, R., Tortorella, D. et al. (2001a). Antigen pre-sentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class II molecule HLA-A2. Proc. Natl Acad. Sci. USA, 98(12), 6794-6799.
48. Gewurz, B. E., Wang, E. W., Tortorella, D. et al. (2001b). Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class II in a locus-specific manner. J. Virol., 75(11), 5197-5204.
49. Gilbert, M. J., Riddell, S. R., Plachter, B. et al. (1996). Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature, 383(6602), 720-722.
50. Goldsmith, K., Chen, W., Johnson, D.C. et al. (1998). Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J. Exp. Med., 187(3), 341-348.
51. Goto, E., Ishido, S., Ohgimoto, S. et al. (2003). c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus pro-teins MIR1 and MIR2 and has similar activity. J. Biol. Chem., 278(17), 14657-14668.
52. Hamman, B. D., Chen, J. C., Johnson, E. E. et al. (1997). The aque-ous pore through the translocon has a diameter of 40-60 A during cotranslational protein translocation at the ER mem-brane. Cell, 89(4), 535-544.
53. Hassink, G. C., Barel, M. T., Van Voorden, S. B. et al.(2006). Ubiquiti-nation of class II MHC heavy chains is essential for dislocation by human cytomegalovirus-encoded US2 but not US11. J. Biol Chem.July, 2006 (in press, epublication)
54. Heemels, M. T. and Ploegh, H. (1995). Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem., 64, 463-491.
55. Heise, M. T., Connick, M., and Virgin, H. W. 4th (1998). Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J. Exp. Med., 187(7), 1037-1046.
56. Hengel, H., Reusch, U., Geginat, G. et al. (2000). Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus. J. Virol., 74(17), 7861-7868.
57. Hertel, L., Lacaille, V. G., Strobl, H. et al. (2003). Suscepti-bility of immature and mature Langerhans cell-type den-dritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol., 77(13), 7563-7574.
58. Hewitt, E. W., Gupta, S. S., Mufti, D. et al. (2001). The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J., 20(3), 387-396.
59. Hewitt, E. W., Duncan, L., Mufti, D. et al. (2002). Ubiquitylation of class II MHC by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J., 21(10), 2418-2429.
60. Hicke, L. (2001). A new ticket for entry into budding vesicles-ubiquitin. Cell, 106(5), 527-530.
61. Hill, A., Jugovic, P. et al.(1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature, 375(6530), 411-415.
62. Holtappels, R., Podlech, J., York, I. et al. (2004). Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epi-tope not presented in infected tissues. J. Exp. Med., 199(1), 131-136.
63. Hudson, A. W., Howley, P. M., and Ploegh, H. L. (2001). A human herpesvirus 7 glycoprotein, U21, diverts major histocompati-bility complex class II molecules to lysosomes. J. Virol., 75(24), 12347-12358.
64. Hudson, A. W., Blom, D., Howley, P. M. et al. (2003). The ER-lumenal domain of the HHV-7 immunoevasin U21 directs class II MHC molecules to lysosomes. Traffic, 4(12), 824-837.
65. Ishido, S., Choi, J. K., Lee, B. S. et al. (2000). Inhibition of nat-ural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity, 13(3), 365-374.
66. Janeway, C. A., Jr. and Medzhitov, R. (2002). Innate immune recog-nition. Annu. Rev. Immunol., 20, 197-216.
67. Jenkins, C., Abendroth, A., and Slobedman, B. (2004). A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J. Virol., 78(3), 1440-1447.
68. Jones, T. R., Wiertz, E. J., Sun, L. et al. (1996). Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class II heavy chains. Proc. Natl Acad. Sci. USA, 93(21), 11327-11333.
69. Kavanagh, D. G., Gold, M. C., Wagner, M. et al. (2001a). The mul-tiple immune-evasion genes of murine cytomegalovirus are not redundant: M4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med., 194(7), 967-978.
70. Kavanagh, D. G., Koszinowski, U. H., and Hill, A. B. (2001b). The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class II MHC at the cell surface and in a pre-Golgi compartment. J. Immunol., 167(7), 3894-3902.
71. Khan, S., Zimmermann, A., Bassler, M. et al. (2004). A cytomegalovirus inhibitor of gamma interferon signaling con-trols immunoproteasome induction. J. Virol., 78(4), 1831-1842.
72. Khanna, R., Burrows, S. R., Steigerwald-Mullen, P. M. et al. (1995). Isolation of cytotoxic T lymphocytes from healthy seropos-itive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: Implications for viral persistence and tumor surveillance. Virology, 214(2), 633-637.
73. Kikkert, M., Hassink, G., Barel, M. et al. (2001). Ubiquitination is essential for human cytomegalovirus US11-mediated disloca-tion of class II MHC molecules from the endoplasmic reticu-lum to the cytosol. Biochem. J., 358(2), 369-377.
74. Knop, M., Finger, A., Brawn, T. et al. (1996). Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast. EMBO. J., 15(4), 753-763.
75. Kobelt, D., Lechmann, M., and Steinkasserer, A. (2003). The interac-tion between dendritic cells and herpes simplex virus-1. Curr. Top. Microbiol. Immunol., 276, 145-161.
76. Koopers-Lalic, D., Reits, E. A., Ressing, M. E. et al.(2005). Vari-celloviruses avoid T cell recognition by UL49.5-mediated inac-tivation of the transporter associated with antigen processing. Proc. Natl. Acad. Sci.102(14): 5144-9.
77. Kruse, M., Rosorius, O., Kratzer, F. et al. (2000). Mature den-dritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol., 74(15), 7127-7136.
78. Kyritsis, C., Gorbulev, S., Hutschenreiter, S. et al. (2001). Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J. Biol. Chem., 276(51), 48031-48039.
79. Lanier, L. L. (2003). Natural killer cell receptor signaling. Curr. Opin. Immunol., 15(3), 308-314.
80. Lee, S., Park, B., and Ahn, K. (2003). Determinant for endoplas-mic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein. J. Virol., 77(3), 2147-2156.
81. Lee, S., Yoon, J., Park, B. et al. (2000). Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class II molecules. J. Virol., 74(23), 11262-11269.
82. Lee, S. P., Brooks, J. M., Al-Jarrah, H. et al. (2004). CD8 T cell recog-nition of endogenously expressed Epstein-Barr virus nuclear antigen 1. J. Exp. Med., 199(10), 1409-1420.
83. Lewandowski, G. A., Lo, D., and Bloom, F. E. et al. (1993). Interfer-ence with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: A possible mechanism of evasion of the immune response. Proc. Natl Acad. Sci. USA, 90(5), 2005-2009.
84. Li, L., Liu, D., Fletcher, L. et al. (2002). Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulo-cyte macrophage-colony-stimulating factor and interleukin-4. Blood, 99(10), 3725-3734.
85. Lilley, B. N. and Ploegh, H. L. (2004). A membrane protein required for dislocation of misfolded proteins from the ER. Nature, 429(6994), 834-840.
86. Lilley, B. N. and Ploegh, H. L. (2005). Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. Proc. Natl Acad. Sci., 102(40), 14296-14301.
87. Lilley, B. N., Tortorella, D., and Ploegh, H. L. (2003). Dislocation of a type I membrane protein requires interactions between membrane-spanning segments within the lipid bilayer. Mol. Biol. Cell., 14(9), 3690-3698.
88. LoPiccolo, D. M., Gold, M. C., Kavanaugh, G. D. et al. (2003). Effec-tive inhibition of K(b)-and D(b)-restricted antigen presenta-tion in primary macrophages by murine cytomegalovirus. J. Virol., 77(1), 301-308.
89. Lorenzo, M. E., Jung, J. U., and Ploegh, H. L. (2002). Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J. Virol., 76(11), 5522-5531.
90. Loureiro, J., Lilley, B. N., Spooner, E. et al.(2006). Signal peptide peptidase is required for dislocation from the endoplasmic reticulum. Nature 441(7095), 894-897.
91. Lusso, P., Malnati, M., De Maria, A. et al. (1991). Productive infection of CD4+ and CD8+ mature human T cell pop-ulations and clones by human herpesvirus 6. Transcrip-tional down-regulation of CD3. J. Immunol., 147(2), 685-691.
92. Lybarger, L., Wang, X., Harris, M. R. et al. (2003). Virus subversion of the class II MHC peptide-loading complex. Immunity, 18(1), 121-130.
93. Machold, R. P., Wiertz, E. J., Jones, T. R. et al. (1997). The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class II heavy chains. J. Exp. Med., 185(2), 363-366.
94. Mansouri, M., Douglas, J., and Rose, P. P. (2006). Kaposi's sar-coma herpesvirus K5 eliminates CD31/PECAM from endothe-lial cells. Blood in press e-publication.
95. McClain, K., Gehrz, R., Grierson, H. et al. (1988). Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies. Am. J. Pediatr. Hematol. Oncol., 10(3), 196-205.
96. Means, R. E., Ishido, S., Alvarez, X. et al. (2002). Multiple endocytic trafficking pathways of class II MHC molecules induced by a Herpesvirus protein. EMBO J., 21(7), 1638-1649.
97. Medzhitov, R. and Janeway, C. A. Jr. (1999). Innate immune induc-tion of the adaptive immune response. Cold Spring Harb. Symp. Quant. Biol., 64, 429-435.
98. Miller, D. M., Rahill, B. M., Boss, J. M. et al. (1998). Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med., 187(5), 675-683.
99. Misaghi, S., Sun, Z. Y., Stern, P. et al. (2004). Structural and functional analysisofhumancytomegalovirus US3 protein. J. Virol., 78(1), 413-423.
100. Momburg, F. and Tan, P. (2002). Tapasin-the keystone of the load-ing complex optimizing peptide binding by class II MHC molecules in the endoplasmic reticulum. Mol. Immunol., 39(3-4), 217-233.
101. Morrow, G., Slobedman, B., Cunningham, A. L. et al. (2003). Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J. Virol., 77(8), 4950-4959.
102. Moutaftsi, M., Brennan, P., Spector, S. A. et al. (2004). Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells. J. Virol., 78(6), 3046-3054.
103. Mullen, M. M., Haan, K. M., Longnecker, R. et al. (2002). Structure of the Epstein-Barr virus gp42 protein bound to the class II MHC receptor HLA-DR1. Mol. Cell., 9(2), 375-385.
104. Nazif, T. and Bogyo, M. (2001). Global analysis of proteasomal sub-strate specificity using positional-scanning libraries of cova-lent inhibitors. Proc. Natl Acad. Sci. USA, 98(6), 2967-3972.
105. Neefjes, J. J., Momburg, F., and Hammerling, G. J. (1993). Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science, 261(5122), 769-771.
106. Neumann, L., Kraas, W., Uebel, S. et al. (1997). The active domain of the herpes simplex virus protein ICP47: A potent inhibitor of the transporter associated with antigen processing. J. Mol. Biol., 272(4), 484-492.
107. Nikkels, A. F., Sadzot-Delvaux, C., and Pierard, G. E. (2004). Absence of intercellular adhesion molecule 1 expression in varicella zoster virus-infected keratinocytes during her-pes zoster: Another immune evasion strategy? Am. J. Der-matopathol., 26(1), 27-32.
108. Orr, M. T., Edelmann, K. H, Vieira, J. et al.(2005). Inhibition of class II MHC Is a Virulence Factor in Herpes Simplex Virus Infection of Mice. PLOS Pathogens, 1(1), 62-71.
109. Owen, D. J. and Evans, P. R. (1998). A structural explanation for the recognition of tyrosine-based endocytotic signals. Science, 282(5392), 1327-1332.
110. Park, B., Oh, H., Lee, S. et al. (2002). The class II MHC homolog of human cytomegalovirus is resistant to down-regulation medi-ated by the unique short region protein (US)2, US3, US6, and US11 gene products. J. Immunol., 168(7), 3464-3469.
111. Park, B., Kim, Y., Shin, J. et al. (2004). Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the class II MHC peptide cargo for immune evasion. Immu-nity, 20(1), 71-85.
112. Pfander, R., Neumann, L., Zweckstetter, M. et al. (1999). Struc-ture of the active domain of the herpes simplex virus protein ICP47 in water/sodium dodecyl sulfate solution determined by nuclear magnetic resonance spectroscopy. Biochemistry, 38(41), 13692-13698.
113. Piguet, V., Wan, L., Borel, C. et al. (2000). HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class II major histocompatibility complexes. Nat. Cell. Biol., 2(3), 163-167.
114. Prichard, M. N., Quenelle, D. C., Bidanset, D. J. et al. (2006). Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID mice. Virology J, 3, 18-20.
115. Radosevich, T. J., Seregina, T., Link, C. J. et al. (2003). Effective sup-pression of class II major histocompatibility complex expres-sion by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure. Hum. Gene. Ther., 14(18), 1765-1775.
116. Rehm, A., Engelsberg, A., Tortorella, D. et al. (2002). Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class II heavy chains in dendritic cells. J. Virol., 76(10), 5043-5050.
117. Ressing, M. E., Keating, S. E., van Leeuwen, D. et al.(2005.) Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. J. Immunol., 174(11), 6829-6838.
118. Ressing, M. E., van Leeuwen, D., Verreck, F. A. (2005). Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion. J. Virol., 79(2), 841-52.
119. Reusch, U., Muranyi, W., Lucin, P. et al. (1999). A cytomegalovirus glycoprotein re-routes class II MHC complexes to lysosomes for degradation. EMBO J., 18(4), 1081-1091.
120. Sanchez, D. J., Coscoy, L., and Ganem, D. (2002). Functional organi-zation of MIR2, a novel viral regulator of selective endocytosis. J. Biol. Chem., 277(8), 6124-6130.
121. Savard, M., Belanger, C., Tardif, M. et al. (2000). Infection of primary human monocytes by Epstein-Barr virus. J. Virol., 74(6), 2612-2619.
122. Scheel, H. and Hofmann, K. (2003). No evidence for PHD Fingers as ubiquitin ligases. Trends Cell. Biol., 13(6), 285-287; author reply 287-288.
123. Schust, D. J., Tortorella, D., and Ploegh, H. L. (1998). Trophoblast class II major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med., 188(3), 497-503.
124. Shamu, C. E., Flierman, D., Ploegh, H. L. et al. (2001). Polyubiqui-tination is required for US11-dependent movement of class II MHC heavy chain from endoplasmic reticulum into cytosol. Mol. Biol. Cell., 12(8), 2546-2555.
125. Shin, J., Park, B. Lee, S. et al.(2006). A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form. J. Vir. 80(11), 5397-5404.
126. Sloan, D. D., Zahariadis, G., Posavad, C. M. et al. (2003). CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase. J. Immunol., 171(12), 6733-6741.
127. Sloan, D. D., Han, J. Y., Sandifer, T. K. et al.(2006). Inhibition of TCR signaling by herpes simplex virus. J. Immunol., 176(3), 1825-1833.
128. Slobedman, B., Mocarski, E. S., Arvin, A. et al. (2002). Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood, 100(8), 2867-2873.
129. Spencer, J. V., Lockridge, K. M., Barry, P. A. et al. (2002). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol., 76(3), 1285-1292.
130. Spriggs, M. K., Armitage, R. J., Comeau, M. R. et al. (1996). The extra-cellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J. Virol., 70(8), 5557-5563.
131. Sullivan, C. S., Grundhoff, A. T., Tevethia, S. et al.(2005). SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature, 432(7042), 682-686.
132. Sutkowski, N., Conrad, B., Thorky-Lawson, D. A. et al. (2001). Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity, 15(4), 579-589.
133. Takatsu, H., Katoh, Y., Shiba, Y. et al. (2001). Golgi-localizing, gamma-adaptin ear homology domain, ADP-ribosylation factor-binding (GGA) proteins interact with acidic dileucine sequences within the cytoplasmic domains of sorting recep-tors through their Vps27p/Hrs/STAM (VHS) domains. J. Biol. Chem., 276(30), 28541-28545.
134. Tellam, J., Connolly, G., Green, K. J. et al. (2004). Endogenous pre-sentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. J. Exp. Med., 199(10), 1421-1431.
135. Tirabassi, R. S. and Ploegh, H. L. (2002). The human cytomegalovirus US8 glycoprotein binds to major histocom-patibility complex class II products. J. Virol., 76(13), 6832-6835.
136. Tirosh, B., M. Furman, H., Tortorella, D. et al. (2003). Protein unfold-ing is not a prerequisite for endoplasmic reticulum-to-cytosol dislocation. J. Biol. Chem., 278(9), 6664-6672.
137. Tirosh, B., Iwakoshi, N. N., Lilley B. N. et al.(2005). Human cytomegalovirus protein US11 provokes an unfolded protein response that may facilitate the degradation of class II major histocompatibility complex products. J. Virol., 79(5), 2768-2779.
138. Tomasec, P., Braud, V. M., Rikards, C. et al. (2000). Surface expres-sion of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science, 287(5455), 1031.
139. Tomazin, R., van Schoot, N. E., Goldsmith, K. et al. (1998). Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J. Virol., 72(3), 2560-2563.
140. Tomazin, R., Boname, J., Hegde, N. R. et al. (1999). Cytomegalovirus US2 destroys two components of the class II MHC path-way, preventing recognition by CD4+ T cells. Nat. Med., 5(9), 1039-1043.
141. Tomescu, C., Law, W. K., and Keles, D. H. (2003). Surface downreg-ulation of major histocompatibility complex class II, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. J. Virol., 77(17), 9669-9684.
142. Tortorella, D., Gewurz, B. E., Furman, M. H. et al. (2000). Viral subversion of the immune system. Annu. Rev. Immunol., 18, 861-926.
143. Van den Berg, B., Clemons, W. M., Jr., Collinson, I. et al. (2004). X-ray structure of a protein-conducting channel. Nature, 427(6969), 36-44.
144. Varadan, R., Assfalg, M., Haririnia, A. et al. (2004). Solution con-formation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J. Biol. Chem., 279(8), 7055-7063.
145. Voges, D., Zwickl, P., and Braumeister, W. (1999). The 26S protea-some: A molecular machine designed for controlled proteoly-sis. Annu. Rev. Biochem., 68, 1015-1068.
146. Voo, K. S., Fu, T., Wang, H. Y. et al. (2004). Evidence for the presen-tation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lym-phocytes. J. Exp. Med., 199(4), 459-470.
147. Wang, X., Lybarger, L., Connors, R. et al. (2004). Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class II and the peptide-loading complex. J. Virol., 78(16), 8673-8686.
148. Wang, X., Ye, Y., Lencer, W. et al.(2006). The viral E3 ubiquitin ligase mK3 uses the Derlin/p97 endoplasmic reticulum-associated degradation pathway to mediate down-regulation of major histocompatibility complex class II proteins. J. Biol. Chem., 281(13), 8636-8644.
149. Wiertz, E. J., Jones, T. R., Sun, L. et al. (1996a). The human cytomegalovirus US11 gene product dislocates class II MHC heavy chains from the endoplasmic reticulum to the cytosol. Cell, 84(5), 769-779.
150. Wiertz, E. J., Tortorella, D., Bogya, M. et al. (1996b). Sec61-mediated transfer of a membrane protein from the endoplasmic retic-ulum to the proteasome for destruction. Nature, 384(6608), 432-438.
151. Willcox, B. E., Thomas, L. M., and Bjorkman, P. J. (2003). Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol., 4(9), 913-919.
152. Wubbolts, R. and Neefjes, J. (1999). Intracellular transport and pep-tide loading of class II MHC molecules: Regulation by chaper-ones and motors. Immunol. Rev., 172, 189-208.
153. Ye, Y., Meyer, H. H., and Rapoport, T. A. (2001). The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature, 414(6864), 652-656.
154. Ye, Y., Shibata, Y., Yun, C. et al. (2004). A membrane protein com-plex mediates retro-translocation from the ER lumen into the cytosol. Nature, 429(6994), 841-847.
155. York, I. A., Roop, C., Andrew, D. W. et al. (1994). A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell, 77(4), 525-535.
156. Zeidler, R., Eissner, G., Meissner, P. et al. (1997). Downregula-tion of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood, 90(6), 2390-2397.
157. Ziegler, H., Muranyi, W., Burgert, H. G. et al. (2000). The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of class II MHC molecules. EMBO. J., 19(5), 870-881.
158. Zimmermann, A., Trilling, M., Wagner, M. et al.(2005). A cytomegaloviral protein reveals a dual role for STAT2 in IFN-Y signaling and antiviral responses. J. Exp. Med., 201(10), 1543-1553.